Candel Therapeutics annual net debt
2020
2021
2022
2023
2024
2025
Candel Therapeutics Net Debt Growth & History (CADL)
Candel Therapeutics's net debt was −$117.8M for fiscal 2025.
View full Candel Therapeutics company overviewCandel Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$117.8M | −$27.8M | — |
| 2024 | 2024-12-31 | −$90.1M | −$76.7M | — |
| 2023 | 2023-12-31 | −$13.4M | $54.7M | — |
| 2022 | 2022-12-31 | −$68.1M | $14.0M | — |
| 2021 | 2021-12-31 | −$82.1M | −$47.5M | — |
| 2020 | 2020-12-31 | −$34.6M | — | — |
Candel Therapeutics quarterly net debt
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$199.9M | −$106.6M | — |
| Q1 2026 | 2026-03-31 | −$193.0M | −$110.9M | — |
| Q4 2025 | 2025-12-31 | −$117.8M | −$27.8M | — |
| Q3 2025 | 2025-09-30 | −$80.7M | −$79.4M | — |
| Q2 2025 | 2025-06-30 | −$93.3M | −$89.6M | — |
| Q1 2025 | 2025-03-31 | −$82.2M | −$76.7M | — |
| Q4 2024 | 2024-12-31 | −$90.1M | −$76.7M | — |
| Q3 2024 | 2024-09-30 | −$1.4M | $19.6M | — |
| Q2 2024 | 2024-06-30 | −$3.7M | $26.1M | — |
| Q1 2024 | 2024-03-31 | −$5.4M | $31.7M | — |
| Q4 2023 | 2023-12-31 | −$13.4M | $54.7M | — |
| Q3 2023 | 2023-09-30 | −$20.9M | $54.2M | — |
| Q2 2023 | 2023-06-30 | −$29.8M | $54.8M | — |
| Q1 2023 | 2023-03-31 | −$37.1M | $54.9M | — |
| Q4 2022 | 2022-12-31 | −$68.1M | $14.0M | — |
| Q3 2022 | 2022-09-30 | −$75.1M | $12.7M | — |
| Q2 2022 | 2022-06-30 | −$84.6M | −$60.8M | — |
| Q1 2022 | 2022-03-31 | −$92.1M | — | — |
| Q4 2021 | 2021-12-31 | −$82.1M | −$47.5M | — |
| Q3 2021 | 2021-09-30 | −$87.8M | — | — |
| Q2 2021 | 2021-06-30 | −$23.8M | — | — |
| Q4 2020 | 2020-12-31 | −$34.6M | — | — |
Candel Therapeutics net debt trends
Over the last five fiscal years, Candel Therapeutics's net debt decreased from −$34.6M to −$117.8M, a change of −$83.3M. The latest reported quarter, Q2 2026, shows −$199.9M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Candel Therapeutics source filings ↗